Definition and measurement of post-COVID-19 conditions in real-world practice: a global systematic literature review

J Yang, K Markus, KM Andersen, AE Rudolph… - BMJ open, 2024 - bmjopen.bmj.com
Post-COVID-19 conditions (PCC) is an umbrella term that encompasses a range of signs,
symptoms and conditions present weeks after the acute phase of a SARS-CoV-2 infection …

[HTML][HTML] Real-World-Time Data and RCT Synergy: Advancing Personalized Medicine and Sarcoma Care through Digital Innovation

P Heesen, G Schelling, M Birbaumer, R Jäger, B Bode… - Cancers, 2024 - mdpi.com
Simple Summary This study looks at how combining real-world/time data/evidence
(RWTD/E) with traditional clinical studies (known as randomized controlled trials) can …

Rates of ICD-10 Code U09. 9 documentation and clinical characteristics of VA patients with Post–COVID-19 Condition

PL Wander, A Baraff, A Fox, K Cho… - JAMA Network …, 2023 - jamanetwork.com
Importance A significant proportion of SARS-CoV-2 infected individuals experience post–
COVID-19 condition months after initial infection. Objective To determine the rates, clinical …

Unlocking the power of benchmarking: real-world-time data analysis for enhanced sarcoma patient outcomes

B Fuchs, G Schelling, M Elyes, G Studer… - Cancers, 2023 - mdpi.com
Simple Summary Benchmarking is a crucial tool for healthcare providers to improve quality
and efficiency, especially for complex conditions like sarcomas. Sarcomas are a type of …

Impact of extended-course oral nirmatrelvir/ritonavir in established Long COVID: a case series

AK Cohen, TW Jaudon, EM Schurman, L Kava… - Communications …, 2024 - nature.com
Background Prior case series suggest that a 5-day course of oral Paxlovid
(nirmatrelvir/ritonavir) benefits some people with Long COVID, within and/or outside of the …

Addressing standardized definitions of post-COVID and long-COVID

G Lippi, BM Henry, J Favresse… - Clinical Chemistry and …, 2023 - degruyter.com
Although the clinical burden of coronavirus disease 2019 (COVID-19) has undergone a
substantial decline over time [1], the consequences of severe acute respiratory syndrome …

Clinical coding of long COVID in primary care 2020–2023 in a cohort of 19 million adults: an OpenSAFELY analysis

AD Henderson, BFC Butler-Cole, J Tazare… - …, 2024 - thelancet.com
Background Long COVID is the patient-coined term for the persistent symptoms of COVID-
19 illness for weeks, months or years following the acute infection. There is a large burden of …

Beyond the clinic: Virtual care as the future of Long COVID rehabilitation

M Anderson, N Bauer - Cardiopulmonary Physical Therapy …, 2025 - journals.lww.com
Background and Purpose: As a result of COVID-19 infection, millions of individuals are now
affected by Long COVID, and this number continues to increase. These individuals …

[HTML][HTML] Impact of extended-course oral nirmatrelvir/ritonavir (Paxlovid) in established Long COVID: Case series and research considerations

AK Cohen, TW Jaudon, EM Schurman, L Kava… - Research …, 2023 - ncbi.nlm.nih.gov
Background: Prior case series suggest that a 5-day course of oral Paxlovid
(nirmatrelvir/ritonavir) benefits some people with Long COVID, within and/or outside of the …

Reengineering a machine learning phenotype to adapt to the changing COVID-19 landscape: A study from the N3C and RECOVER consortia

M Crosskey, T McIntee, S Preiss, D Brannock, YJ Yoo… - medRxiv, 2023 - medrxiv.org
Background In 2021, we used the National COVID Cohort Collaborative (N3C) as part of the
NIH RECOVER Initiative to develop a machine learning (ML) pipeline to identify patients …